All lots of JAMP-Clopidogrel 75 mg and AG-Clopidogrel 75 mg tablets recalled due to possible incorrect dose, which may pose health risks
Why it was recalled
Product safety - Dosage
What you should do
If you are taking the affected products, speak with your pharmacist as soon as possible. It may not be possible to know if you are getting the correct dose of clopidogrel by looking at the tablets since overweight or underweight tablets may look like normal-sized tablets.Continue taking your JAMP-Clopidogrel 75 mg or AG-Clopidogrel 75 mg tablets until you speak with your pharmacist and get a replacement product.Contact a health care professional immediately if you or someone you are caring for experiences serious side effects related to an incorrect dose of clopidogrel.If you have questions about this recall, contact JAMP Pharma Corporation by calling toll-free at 1-866-399-9091, extension 501, or by email at custjamp@jamppharma.com, or Angita Pharma Inc. at 450-449-9272 or by email at custangita@angitapharma.ca.Report any health product-related side effects or complaints to Health Canada.
Other Recent Recalls
Apo-Semaglutide Injection
Apo-Semaglutide Injection : Incorrect dose display
Moderate health risk
Novo-Gesic Forte 500 mg tablets (acetaminophen)
Generic acetaminophen by Teva recalled because it may contain foreign material
Highest health risk
JAMP Temozolomide
JAMP Temozolomide: Out-of-Specification (Assay)
Moderate health risk
Recall data is sourced from Health Canada's Recalls and Safety Alerts open dataset. MedShort.ca is an independent tracking tool and does not provide medical advice — for questions about this recall, contact the manufacturer or your pharmacist, or read the full notice linked above.